Hims & Hers Health (HIMS)
Connects personalized treatment plans with telehealth consultations and pharmacy fulfillment.
$29.44
vs last close−0.99 (−3.25%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 227 | 247 | 278 | 316 | 402 | 481 | 586 | 545 | 599 | 618 | 608 | 753 |
| Cost of revenue | 39 | 43 | 49 | 59 | 84 | 112 | 155 | 129 | 157 | 173 | 308 | 272 |
| Gross profit | 187 | 204 | 229 | 257 | 318 | 370 | 431 | 416 | 442 | 444 | 300 | 481 |
| 196 | 204 | 219 | 246 | 296 | 351 | 373 | 389 | 430 | 435 | 317 | 578 | |
| Research & development | 12 | 13 | 15 | 19 | 21 | 24 | 30 | 38 | 41 | 41 | 47 | 0 |
| 152 | 158 | 165 | 185 | 227 | 269 | 280 | 285 | 313 | 314 | 332 | 428 | |
| Selling & marketing | 116 | 126 | 131 | 145 | 182 | 221 | 231 | 218 | 232 | 238 | 222 | 262 |
| General & administrative | 36 | 32 | 35 | 41 | 45 | 48 | 49 | 67 | 81 | 76 | 110 | 165 |
| Other expenses | 32 | 33 | 39 | 41 | 48 | 58 | 63 | 66 | 77 | 80 | −62 | 150 |
| Operating income | −9 | 0 | 10 | 11 | 22 | 19 | 58 | 27 | 12 | 9 | −16 | −97 |
| 2 | 3 | 3 | 2 | 1 | 4 | 3 | 6 | 0 | 9 | −85 | 5 | |
| Other non-operating income | 0 | −3 | −3 | −2 | −1 | −4 | −3 | −6 | 0 | −9 | 85 | −5 |
| Income before tax | −7 | 2 | 12 | 13 | 24 | 22 | 60 | 33 | 12 | 18 | −102 | −93 |
| Income tax expense | 1 | 1 | 1 | 0 | −52 | −4 | 11 | −10 | −4 | −2 | −9 | −6 |
| Net income from continuing operations | −8 | 1 | 11 | 13 | 76 | 26 | 49 | 43 | 16 | 21 | −92 | −86 |
| Net income | −8 | 1 | 11 | 13 | 76 | 26 | 49 | 43 | 16 | 21 | −92 | −86 |
| EPS, basic | −$0.04 | $0.01 | $0.05 | $0.06 | $0.35 | $0.12 | $0.22 | $0.19 | $0.07 | $0.09 | −$0.40 | −$0.37 |
| EPS, diluted | −$0.04 | $0.01 | $0.05 | $0.06 | $0.32 | $0.11 | $0.20 | $0.17 | $0.06 | $0.08 | −$0.40 | −$0.37 |
| Weighted average shares, basic | 210 | 210 | 213 | 215 | 217 | 219 | 222 | 224 | 226 | 227 | 228 | 232 |
| Weighted average shares, diluted | 210 | 210 | 229 | 235 | 235 | 241 | 247 | 257 | 249 | 248 | 228 | 232 |
| EBITDA | −6 | 5 | 15 | 17 | 28 | 28 | 69 | 43 | 30 | 36 | −80 | −63 |
| Depreciation & amortization | 2 | 3 | 3 | 4 | 4 | 6 | 8 | 10 | 18 | 18 | 22 | 29 |
| EBIT | −9 | 2 | 12 | 13 | 24 | 22 | 60 | 33 | 12 | 18 | −102 | −93 |